Clinical trial · Observational
Hepatobiliary and Pancreatic Tumor Biobank
Establishment of a Hepatobiliary and Pancreatic Tumor Biobank at a Single Academic Medical Center
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study aims to establish a hepatobiliary and pancreatic tumor biobank at the Second Affiliated Hospital of Zhejiang University School of Medicine. The biobank will systematically collect and store human biological samples, such as blood, tissue, bile, and other body fluids, together with relevant clinical and follow-up information from patients with hepatobiliary and pancreatic tumors, benign hepatobiliary and pancreatic diseases, and selected healthy volunteers. The collection of samples will be performed without changing routine medical care and will not involve any experimental treatment or additional invasive procedures for research purposes. Biological samples will be obtained during standard clinical diagnosis and treatment, or from remaining specimens after routine clinical use. All samples and data will be coded and stored according to ethical and legal requirements to protect participants' privacy. The biobank is intended to serve as a long-term research resource to support future basic, translational, and clinical research on hepatobiliary and pancreatic diseases, with the goal of improving understanding of disease mechanisms and advancing medical research in this field.
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cholangiocarcinoma | Cholangiocarcinoma | ONTOLOGY_EXACT | 0.98 |
| Hepotacellular Carcinoma | Pancreatic Neoplasm | PROBABILISTIC | 0.70 |
| Pancreatic Cancer | Malignant Pancreatic Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| No Interventions | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Hepatobiliary and Pancreatic Biobank Participants
- description
- Participants enrolled in this observational biobank study, including patients with hepatobiliary and pancreatic malignant tumors, patients with benign hepatobiliary and pancreatic diseases, and selected healthy volunteers. Biological specimens and related clinical data are collected during routine clinical care without experimental interventions.
- interventionNames
- Other: No Interventions
Primary outcomes (1)
- measure
- Successful Establishment of a Hepatobiliary and Pancreatic Tumor Biobank
- timeFrame
- up to 5 years
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Adults aged 18 years or older. * Patients diagnosed with hepatobiliary or pancreatic malignant tumors, including but not limited to hepatocellular carcinoma, cholangiocarcinoma, gallbladder cancer, and pancreatic cancer; or patients with benign hepatobiliary or pancreatic diseases; or selected healthy volunteers. * Receiving medical care or health evaluation at the Second Affiliated Hospital of Zhejiang University School of Medicine. * Able and willing to provide written informed consent, unless waived or exempted by the institutional ethics committee for retrospective samples. * Willing to allow collection and storage of biological specimens and related clinical data for research purposes. Exclusion Criteria: * Age younger than 18 years. * Unable to provide informed consent and without a legally authorized representative. * Presence of conditions that, in the opinion of the investigators, make participation inappropriate or infeasible. * Refusal to allow the collection or use of biological specimens or clinical data for research.
References
Publications (0)
Data not yet available